antitrust

Pfizer inks another EpiPen antitrust settlement, this one worth $50
Fierce Pharma
Wed, 10/11/23 - 11:48 pm
Pfizer
EpiPen
antitrust
class action lawsuits
Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case
Fierce Pharma
Tue, 09/26/23 - 11:47 am
Gilead Sciences
Teva Pharmaceutical
HIV
legal
antitrust
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Thu, 09/21/23 - 11:51 am
Takeda
generics
gout
Colcrys
antitrust
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
BioSpace
Wed, 09/20/23 - 08:59 am
Amgen
Horizon Therapeutics
FTC
antitrust
M&A
New antitrust merger guidelines could have chilling effect on healthcare deals
BioPharma Dive
Sun, 07/23/23 - 12:45 pm
antitrust
FTC
M&A
FTC Scrutiny Chills Medtech M&A Market
Medical Devices and Diagnostics Industry
Wed, 07/5/23 - 11:47 am
Medtech
M&A
FTC
antitrust
FTC proposes updates to merger review that could slow healthcare dealmaking
BioPharma Dive
Wed, 06/28/23 - 10:38 pm
FTC
M&A
antitrust
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Fierce Pharma
Mon, 05/29/23 - 12:26 pm
Gilead Sciences
Teva Pharmaceutical
HIV
legal
antitrust
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Thu, 05/25/23 - 01:10 pm
Gilead Sciences
Teva Pharmaceutical
legal
HIV
antitrust
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Mon, 05/15/23 - 11:19 am
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
Fierce Pharma
Fri, 04/21/23 - 10:20 am
Merck
Glenmark
Zetia
pay-for-delay
antitrust
legal
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Fierce Pharma
Mon, 04/3/23 - 10:51 pm
Viatris
EpiPen
Mylan
legal
antitrust
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
Mon, 03/20/23 - 09:50 am
JNJ
legal
Remicade
antitrust
biosimilars
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
Tue, 03/14/23 - 06:28 pm
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Fri, 02/24/23 - 08:55 am
Amarin
Hikma
legal
antitrust
generics
Vascepa
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Wed, 02/22/23 - 06:54 pm
Gilead Sciences
legal
HIV
antitrust
Teva Pharmaceutical
JNJ

Pages